Imaging: Nanoscopy at low light intensities shows its potential
The availability of fluorescence microscopes that can image sub-cellular structures labelled by fluorescent markers in living cells has provided fresh insights into a variety of cellular processes and functions. For most of the 20th century the resolution of such lens-based microscopes was limited by diffraction of the light used to form the image. This diffraction limit is about half the wavelength of the light, which means that an optical microscope cannot achieve a resolution any better than about 250 nm. In 1994, however, Stefan Hell and Jan Wichmann predicted that the diffraction limit could be beaten by a new form of fluorescence microscopy called stimulated emission depletion (STED) microscopy (Hell and Wichmann, 1994). This approach and related techniques are now routinely used to image fixed and living cells with a resolution of better than 100 nm (Gould et al., 2012). However, the high light intensities needed for these forms of ‘nanoscopy’, combined with relatively slow imaging speeds, can be problematic when imaging living samples. Now, in eLife, Hell and co-workers report that a new fluorescent marker called rsEGFP2 allows them to image living cells at low light intensities some 25–250 times faster than was possible previously (Grotjohann et al., 2012).
In fluorescence microscopy, fluorescent markers (also known as fluorophores) are excited by a bright light source, often a laser. After a short time the excited fluorophore returns to its electronic ground state by releasing a fluorescence photon, and an image of the sample can be built up by detecting these photons. Whereas the resolution of a conventional microscope is determined by the optics of the instrument, the resolution achievable with a fluorescence nanoscope depends on both the optics and the properties of the fluorophore. The diffraction limit is overcome by switching the fluorophores in the sample on and off (Hell, 2009). In STED microscopy, for example, a second laser is used to transfer the fluorophore from the excited state to the ground state without fluorescing. By focusing the second laser (the depletion laser) in a ring shape, and then overlaying this pattern on the first laser, it is possible to effectively switch off all of the fluorophores, apart from those very close to the centre of the ring (where the intensity of the depletion laser is negligible; Figure 1). This targeted switching approach thereby creates a sub-diffraction sized region from which fluorescence can be emitted. A ‘super-resolution’ image is built up by scanning the two laser foci across the sample and recording the fluorescence signal.
The resolution of STED microscopes is given by the equation Δr ≈ λ/(2NA(1+Imax/Isat)1/2), where λ is the wavelength of the depletion laser, NA is the numerical aperture of the objective lens, Imax is the peak intensity of the depletion laser, and Isat is the saturation intensity of the fluorophore (that is, the intensity at which 50% of the fluorescence is depleted; Hell, 2009). The size of the fluorescent region can, in principle, be made arbitrarily small by increasing the peak intensity of the depletion laser Imax or by using a fluorophore with a low saturation intensity Isat, which can be achieved by using a fluorophore with a long excited state lifetime Tfluor (because Isat is inversely proportional to Tfluor). Due to the short lifetimes of most fluorophores, which are on the order of nanoseconds, the saturation intensity Isat is typically ∼104 kW/cm2 (Hell, 2009). This means that the peak intensity of the depletion laser Imax needs to be higher than ∼105 kW/cm2 to push the resolution significantly below the diffraction limit. In addition to limiting laser choice, such high intensities raise concerns that living specimens could suffer long-term photodamage.
Targeted switching can, in principle, be used with any reversibly switchable optical transition, not just stimulated emission, as described by the RESOLFT principle (Hell et al., 2003). By choosing a transition with a lifetime that is much longer than Tfluor, it is possible to push the resolution well below the diffraction limit with laser intensities much lower than those used in STED microscopy. One variant of RESOLFT nanoscopy has recently come to fruition in biological imaging experiments using fluorescent proteins that can be reversibly switched between two states (Brakemann et al., 2011; Grotjohann et al., 2011; Testa et al., 2012).
These approaches require three illumination steps: one for activation, one for targeted deactivation and one for readout of the remaining activated probe molecules. For example RESOLFT nanoscopy using rsEGFP (reversibly switching enhanced green fluorescent protein) works as follows: first, a diffraction-limited violet laser focus is used to activate the fluorophores (i.e., switch them to a state that is capable of fluorescence). Second, a ring-shaped blue laser focus repeatedly excites the activated molecules to fluoresce, although this fluorescence is not recorded, and eventually deactivates them (i.e., switches them to a fluorescence incapable state). Laser light of the same colour, but conventionally focused, is then used to excite the remaining activated fluorophores at the centre of the ring and the fluorescence from this sub-diffraction area is detected. This three-step process is repeated for every pixel of the super-resolution image. Due to the long lifetime of the activated state, low intensities of the ring-shaped focus of Imax ∼1 to 10 kW/cm2 have been sufficient to achieve sub-100 nm resolution. However, the long pixel dwell times required by the slow switching kinetics of the fluorophore, rsEGFP, have led to image acquisition times of up to about an hour in the past (Grotjohann et al., 2011).
Now Hell and co-workers—including Tim Grotjohann and Ilaria Testa of the Max Planck Institute for Biophysical Chemistry as joint first authors, and Stefan Jakobs as joint corresponding author—report that they have modified this protein to make a new fluorophore called rsEGFP2 with a shorter switching time and improved resistance to switching fatigue (Grotjohann et al., 2012). This has allowed them to image various structures inside living cells 25–250 times faster than previously reported. Importantly, the relatively low laser intensities (∼1 to 80 kW/cm2 in a laser scanning configuration in which every point of the sample is illuminated for only a fraction of the frame acquisition time) needed to switch off the fluorescence mean that this approach exposes samples to the lowest radiation doses of all the nanoscopy techniques demonstrated to date.
Compared to STED nanoscopy, the current approach to RESOLFT nanoscopy requires additional activation and deactivation steps before the actual fluorescence can be recorded (see Figure 1). These steps inherently add overhead to the imaging process, and this slows down data acquisition. However, the advent of new fluorescent proteins such as rsEGFP2 extends RESOLFT nanoscopy with photoswitchable markers to faster live-cell imaging and holds great promise for future biological applications. The use of low light intensities results in reduced phototoxicity and is likely to allow imaging over extended time periods. Temporal resolution can be further improved using parallelization techniques and, if combined with faster switching rates, this should lead to video-rate RESOLFT nanoscopy over large fields of view.
References
-
Optical nanoscopy: from acquisition to analysisAnnu Rev Biomed Eng 14:231–254.https://doi.org/10.1146/annurev-bioeng-071811-150025
Article and author information
Author details
Publication history
Copyright
© 2012, Gould and Bewersdorf
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 511
- views
-
- 54
- downloads
-
- 6
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Structural Biology and Molecular Biophysics
Osmotic stress and chloride regulate the autophosphorylation and activity of the WNK1 and WNK3 kinase domains. The kinase domain of unphosphorylated WNK1 (uWNK1) is an asymmetric dimer possessing water molecules conserved in multiple uWNK1 crystal structures. Conserved waters are present in two networks, referred to here as conserved water networks 1 and 2 (CWN1 and CWN2). Here, we show that PEG400 applied to crystals of dimeric uWNK1 induces de-dimerization. Both the WNK1 the water networks and the chloride-binding site are disrupted by PEG400. CWN1 is surrounded by a cluster of pan-WNK-conserved charged residues. Here, we mutagenized these charges in WNK3, a highly active WNK isoform kinase domain, and WNK1, the isoform best studied crystallographically. Mutation of E314 in the Activation Loop of WNK3 (WNK3/E314Q and WNK3/E314A, and the homologous WNK1/E388A) enhanced the rate of autophosphorylation, and reduced chloride sensitivity. Other WNK3 mutants reduced the rate of autophosphorylation activity coupled with greater chloride sensitivity than wild-type. The water and chloride regulation thus appear linked. The lower activity of some mutants may reflect effects on catalysis. Crystallography showed that activating mutants introduced conformational changes in similar parts of the structure to those induced by PEG400. WNK activating mutations and crystallography support a role for CWN1 in WNK inhibition consistent with water functioning as an allosteric ligand.
-
- Structural Biology and Molecular Biophysics
Peroxisome proliferator-activated receptor gamma (PPARγ) is a nuclear receptor transcription factor that regulates gene expression programs in response to ligand binding. Endogenous and synthetic ligands, including covalent antagonist inhibitors GW9662 and T0070907, are thought to compete for the orthosteric pocket in the ligand-binding domain (LBD). However, we previously showed that synthetic PPARγ ligands can cooperatively cobind with and reposition a bound endogenous orthosteric ligand to an alternate site, synergistically regulating PPARγ structure and function (Shang et al., 2018). Here, we reveal the structural mechanism of cobinding between a synthetic covalent antagonist inhibitor with other synthetic ligands. Biochemical and NMR data show that covalent inhibitors weaken—but do not prevent—the binding of other ligands via an allosteric mechanism, rather than direct ligand clashing, by shifting the LBD ensemble toward a transcriptionally repressive conformation, which structurally clashes with orthosteric ligand binding. Crystal structures reveal different cobinding mechanisms including alternate site binding to unexpectedly adopting an orthosteric binding mode by altering the covalent inhibitor binding pose. Our findings highlight the significant flexibility of the PPARγ orthosteric pocket, its ability to accommodate multiple ligands, and demonstrate that GW9662 and T0070907 should not be used as chemical tools to inhibit ligand binding to PPARγ.